121 related articles for article (PubMed ID: 9416424)
21. Novel dithiocarbamate carbapenems with anti-MRSA activity.
Ohtake N; Imamura H; Jona H; Kiyonaga H; Shimizu A; Moriya M; Sato H; Nakano M; Ushijima R; Nakagawa S
Bioorg Med Chem; 1998 Jul; 6(7):1089-101. PubMed ID: 9730246
[TBL] [Abstract][Full Text] [Related]
22. CW-270033, a novel pyrrolidinyl-thio carbapenem, has potent antimicrobial activity in vitro and in vivo.
Kim J; Ha JR; Oh SW; Kim HG; Lee JM; Lee DG; Lee SH; Kim JG
Biol Pharm Bull; 2007 Mar; 30(3):575-9. PubMed ID: 17329859
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and structure-activity relationships of novel parenteral carbapenems, CS-023 (R-115685) and related compounds containing an amidine moiety.
Kawamoto I; Shimoji Y; Kanno O; Kojima K; Ishikawa K; Matsuyama E; Ashida Y; Shibayama T; Fukuoka T; Ohya S
J Antibiot (Tokyo); 2003 Jun; 56(6):565-79. PubMed ID: 12931867
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and in vitro activity of 1 beta-methyl C-2 quaternary heterocyclic alkylthio carbapenems.
Kim CU; Luh BY; Misco PF; Hitchcock JM
J Med Chem; 1989 Mar; 32(3):601-4. PubMed ID: 2918506
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa.
Shibata K; Adachi Y; Kato E; Nagano R; Fuse A; Hashizume T; Ohtake N; Okamoto O; Nakagawa S
J Antibiot (Tokyo); 1997 Feb; 50(2):135-8. PubMed ID: 9099222
[TBL] [Abstract][Full Text] [Related]
26. Structure-activity relationships of 1 beta-methyl-carbapenems to antimicrobial activity: effect of C-6 substituent.
Sunagawa M; Matsumura H; Sasaki A; Yamaga H; Kitamura Y; Sumita Y; Nouda H
J Antibiot (Tokyo); 1997 Jul; 50(7):621-7. PubMed ID: 9711254
[No Abstract] [Full Text] [Related]
27. Synthesis and antibacterial activities of new 1beta-methylcarbapenems having aminopyrimidinylthioether moiety.
Lee KS; Lim JH; Kang YK; Yoo KH; Kim DC; Shin KJ; Kim DJ
Eur J Med Chem; 2006 Nov; 41(11):1347-51. PubMed ID: 16973246
[TBL] [Abstract][Full Text] [Related]
28. Dicationic dithiocarbamate carbapenems with anti-MRSA activity.
Imamura H; Ohtake N; Jona H; Shimizu A; Moriya M; Sato H; Sugimoto Y; Ikeura C; Kiyonaga H; Nakano M; Nagano R; Abe S; Yamada K; Hashizume T; Morishima H
Bioorg Med Chem; 2001 Jun; 9(6):1571-8. PubMed ID: 11408176
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antibacterial activity of 1beta-methylcarbapenems having a 2, 2-disubstituted-1, 3-diazabicyclo[3.3.0]octan-4-one moiety and related compounds. Part III.
Oh CH; Dong HG; Cho HW; Park SJ; Hong JH; Baek D; Cho JH
Arch Pharm (Weinheim); 2002 May; 335(5):200-6. PubMed ID: 12210776
[TBL] [Abstract][Full Text] [Related]
30. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
[TBL] [Abstract][Full Text] [Related]
31. Studies on the synthesis and antibacterial activity of new zwitterionic carbapenems.
Oh CH; Cho JH
J Antibiot (Tokyo); 1994 Jan; 47(1):126-8. PubMed ID: 8119856
[No Abstract] [Full Text] [Related]
32. Synthesis and biological properties of new 1beta-methylcarbapenems containing heteroaromatic thioether moiety.
Shin KJ; Koo KD; Yoo KH; Kang YK; Park SW; Kim DJ
Bioorg Med Chem Lett; 2001 Sep; 11(17):2397-9. PubMed ID: 11527740
[TBL] [Abstract][Full Text] [Related]
33. Postantibiotic effect of carbapenems against Pseudomonas aeruginosa.
Hikida M; Yamazaki Y; Yoshida M; Kawashima K; Nishiki K; Mitsuhashi S
J Antibiot (Tokyo); 1995 Aug; 48(8):891-2. PubMed ID: 7592037
[No Abstract] [Full Text] [Related]
34. Laboratory data which differentiate meropenem and imipenem.
Edwards JR; Turner PJ
Scand J Infect Dis Suppl; 1995; 96():5-10. PubMed ID: 7652504
[TBL] [Abstract][Full Text] [Related]
35. A novel carbapenem antibiotic, SM-7338 structure-activity relationships.
Sunagawa M; Matsumura H; Inoue T; Fukasawa M; Kato M
J Antibiot (Tokyo); 1990 May; 43(5):519-32. PubMed ID: 2358404
[TBL] [Abstract][Full Text] [Related]
36. Kinetic analysis of dehydropeptidase-I and comparative in vitro and in vivo stabilities of PS-5 derivatives modified at the C-3 side chain.
Sakamoto M; Yamamoto K; Isshiki K; Tone H; Ishikura T; Fukagawa Y; Yoshioka T
Chem Pharm Bull (Tokyo); 1991 Feb; 39(2):341-8. PubMed ID: 2054858
[TBL] [Abstract][Full Text] [Related]
37. Studies on the synthesis and structure-activity relationships of 2-(2-functionalized pyrrolidin-4-ylthio)-1 beta-methylcarbapenems.
Lee HW; Kim EN; Son HJ; Ahn SK; Chung KH; Kim JW; Lee CR
Chem Pharm Bull (Tokyo); 1996 Dec; 44(12):2326-30. PubMed ID: 8996864
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antibacterial activity of 1 beta-methyl-2-(5-substituted imidazolino pyrrolidin-3-ylthio)carbapenem derivatives.
Oh CH; Lee CS; Lee JS; Cho JH
Arch Pharm (Weinheim); 2003 Nov; 336(11):504-9. PubMed ID: 14639742
[TBL] [Abstract][Full Text] [Related]
39. Emerging strategies in infectious diseases: new carbapenem and trinem antibacterial agents.
Sader HS; Gales AC
Drugs; 2001; 61(5):553-64. PubMed ID: 11368281
[TBL] [Abstract][Full Text] [Related]
40. Studies on the synthesis and antibacterial activity of new carbamoylpyrrolidinylthiocarbapenems.
Lee HW; Kim EN; Son HJ; Kim KK; Kim JK; Lee CR; Kim JW
J Antibiot (Tokyo); 1995 Sep; 48(9):1046-8. PubMed ID: 7592052
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
